MedTrace Logo

CareLink Connect - Technical Evaluation Study

NCT01989975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the performance, patient satisfaction and safety of connectivity gateway device CareLink Connect, transferring CGM (Continuous Glucose Monitoring) data from a VEO insulin pump to CareLink online (every 5th minute) and thereby making it available for patients or Care Partners individual web connected devices such as smartphones, tablets and PCs.

Conditions

Sponsors & Collaborators

  • Medtronic Diabetes

    lead INDUSTRY

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Denmark
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01989975 on ClinicalTrials.gov